Trial Site Detail
Drug: |
Rogaratinib |
|||
|---|---|---|---|---|
Trial: |
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) |
|||
| Conditions: | Sarcoma | |||
Trial Status: |
Completed |
|||
University of Michigan1500 East Medical Center Dr |
Principal Investigator: |
Scott M Schuetze |
|---|---|
Contact: |
Contact: Site Public Contact 800-865-1125 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Michigan Website: |
https://www.umms.med.umich.edu/engage/disp_pub_main.do |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.